TOKYO--Yamanouchi Pharmaceutical Co., Japan's third-largest drug manufacturer, is planning to expand its presence in the lucrative pharmaceuticals market in the United States through a newly formed American subsidiary.
The Paramus, N.J.-based division, Yamanouchi Pharma America Inc., will develop and market drugs in the U.S., which generated a global market-leading $172 billion in sales last year.
Yamanouchi Pharma America, which currently is leasing office space, sponsoring gatherings of doctors and recruiting a team of veteran American pharmaceutical executives and hundreds of researchers, marketers and other associates, is developing a treatment for …
No comments:
Post a Comment